These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 526719)
1. Application of the phenotyped panel approach to the detection of polymorphism of drug oxidation in man [proceedings]. Idle JR; Sloan TP; Smith RL; Wakile LA Br J Pharmacol; 1979 Jul; 66(3):430P-431P. PubMed ID: 526719 [No Abstract] [Full Text] [Related]
2. Drug metabolism in uremia. Reidenberg MM Clin Nephrol; 1975; 4(3):83-5. PubMed ID: 1102176 [No Abstract] [Full Text] [Related]
3. Defective oxidation of drugs: pharmacokinetic and therapeutic implications. Eichelbaum M Clin Pharmacokinet; 1982; 7(1):1-22. PubMed ID: 7042170 [No Abstract] [Full Text] [Related]
4. Polymorphic drug oxidation in humans. Eichelbaum M Fed Proc; 1984 May; 43(8):2298-302. PubMed ID: 6714436 [TBL] [Abstract][Full Text] [Related]
5. [Genetic polymorphism of oxidative drug metabolism. Therapeutic and toxicologic implications]. Eichelbaum M Internist (Berl); 1983 Mar; 24(3):117-27. PubMed ID: 6135670 [No Abstract] [Full Text] [Related]
6. Interindividual differences in rates of drug oxidation in man. Davies DS; Thorgeirsson SS; Breckenridge A; Orme M Drug Metab Dispos; 1973; 1(1):411-7. PubMed ID: 4149412 [No Abstract] [Full Text] [Related]
7. Interindividual differences in drug oxidation: clinical importance. Sjöqvist F; von Bahr C Drug Metab Dispos; 1973; 1(1):469-82. PubMed ID: 4149420 [No Abstract] [Full Text] [Related]
8. [Alcohol and drugs]. De Baere H Tijdschr Gastroenterol; 1976; 19(2):117-23. PubMed ID: 1013984 [No Abstract] [Full Text] [Related]
9. Genetic factors in hepatic drug oxidation. Kalow W; Inaba T Prog Liver Dis; 1976; 5():246-58. PubMed ID: 775542 [No Abstract] [Full Text] [Related]
10. Polymorphisms of oxidation at carbon centers of drugs and their clinical significance. Idle JR; Smith RL Drug Metab Rev; 1979; 9(2):301-17. PubMed ID: 158499 [No Abstract] [Full Text] [Related]
11. Pharmacogenetic polymorphism of drug metabolism. Paxton JW N Z Med J; 1984 Aug; 97(762):567-9. PubMed ID: 6591031 [No Abstract] [Full Text] [Related]
12. The genetic control of drug oxidation in the liver. Dayer P; Balant L; Fabre J Int J Clin Pharmacol Res; 1983; 3(6):421-5. PubMed ID: 6147316 [TBL] [Abstract][Full Text] [Related]
13. [Individual variations in the oxidative metabolism of drugs. Significance of monogenic polymorphism]. Brøsen K Ugeskr Laeger; 1984 Mar; 146(13):955-9. PubMed ID: 6719598 [No Abstract] [Full Text] [Related]
14. Pharmacogenetically hazardous drugs: a proposed new scoring method. Szórády I; Sánta A Acta Physiol Hung; 1991; 77(3-4):305-18. PubMed ID: 1755332 [TBL] [Abstract][Full Text] [Related]
15. [Genetic polymorphism of the hepatic metabolism of drugs]. Larrey D; Pessayre D; Benhamou JP Gastroenterol Clin Biol; 1985; 9(6-7):522-31. PubMed ID: 3926587 [No Abstract] [Full Text] [Related]
16. Definition and implications of dose-dependent kinetics in clinical medicine. Holtzman JL Drug Metab Rev; 1983; 14(6):1103-17. PubMed ID: 6426917 [No Abstract] [Full Text] [Related]
17. Genetic factors in drug therapy. Evans DA Sci Basis Med Annu Rev; 1969; ():166-82. PubMed ID: 4918368 [No Abstract] [Full Text] [Related]
18. [Genetic causes for the variability of effects and side effects of drugs]. Roots I Internist (Berl); 1982 Nov; 23(11):601-9. PubMed ID: 6759450 [No Abstract] [Full Text] [Related]
19. Human cytochrome P450: possible roles of drug-metabolizing enzymes and polymorphic drug oxidation in addiction. Gonzalez FJ NIDA Res Monogr; 1991; 111():202-13. PubMed ID: 1775182 [No Abstract] [Full Text] [Related]
20. [Methods for studying the hepatic metabolism of drugs in man]. Geneve J; Bergmann JF; Caulin C; Segrestaa JM Therapie; 1990; 45(2):91-7. PubMed ID: 2191470 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]